SA’s ARV programme hardly grew in 2025, according to latest estimates

The number of people in South Africa on antiretroviral treatment remained roughly unchanged from 2024 to 2025, according to just-published estimates from the leading mathematical model of HIV in the country. This suggests that the disruption of US aid for HIV services has slowed the growth of our HIV treatment programme, but the impact so far is not as severe as some researchers feared it might be. Marcus Low reports.

Read More

Inside The Box with Dr Andy Gray | How can we know that medicines sold in pharmacies are of good quality?

We can generally trust that the medicines we buy at pharmacies contain what they are supposed to and that they were manufactured according to good quality standards. In his latest column, Dr Andy Gray zooms in on the regulatory scaffolding that enables this trust.

Read More

To the US and back: SA’s Prof Willem Hanekom reflects on the joys of science and a career ‘running with opportunities’

At his Durban office, Professor Willem Hanekom tells Biénne Huisman about taking a ventilated young patient to the Sea Point promenade, living with HIV, the need for an African research agenda, and the recurring joy that has defined his career. 

Read More